The Claim

Long-term use of propylthiouracil in patients with Graves disease, particularly those with preexisting autoimmune conditions such as rheumatoid arthritis, is associated with the development of antineutrophil cytoplasmic antibody-associated vasculitis, which can result in acute kidney injury and hypertension, requiring drug discontinuation and immunosuppressive therapy.

Source: A grave complication: propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
30score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Correlation
1 study reviewed
In plain English

Long-term use of the drug propylthiouracil in patients with Graves disease and preexisting autoimmune conditions like rheumatoid arthritis is linked to the development of ANCA-associated vasculitis, a severe inflammatory condition that can cause acute kidney injury and high blood pressure, and requires stopping the drug and starting immunosuppressive treatment.

See the scientific wording

Long-term use of propylthiouracil (PTU) in patients with Graves disease, particularly those with preexisting autoimmune conditions like rheumatoid arthritis, is associated with the development of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, a rare but severe inflammatory condition that can cause acute kidney injury and hypertension, necessitating drug discontinuation and immunosuppressive therapy for recovery.

Why this might work

Propylthiouracil is broken down inside white blood cells into reactive chemicals that change the shape of certain proteins. The immune system sees these changed proteins as foreign and makes antibodies against them. These antibodies attack the white blood cells, causing them to burst and damage small blood vessels, especially in the kidneys, leading to kidney failure and high blood pressure.

Supported mechanismbased on 1 study

What the research says

1 study
  1. Study: A grave complication: propylthiouracil-induced antineutrophil cytoplasmic antibody-associated vasculitis

    A woman with an overactive thyroid took PTU for five years and then got a rare, serious kidney and blood vessel disease. When doctors stopped the drug and gave her anti-inflammatory medicine, she got better. This shows PTU might cause this problem in some people.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.